VBIV

VBI Vaccines Inc
0.612
-0.0301 (-4.69%)
Company Name Stock Ticker Symbol Market Type
VBI Vaccines Inc VBIV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0301 -4.69% 0.612 19:46:01
Open Price Low Price High Price Close Price Prev Close
0.6398 0.61 0.6649 0.615 0.6421
more quote information »

Recent News

Date Time Source Heading
1/30/202317:06EDGARStatement of Changes in Beneficial Ownership (4)
1/30/202317:05EDGARStatement of Changes in Beneficial Ownership (4)
1/30/202317:04EDGARStatement of Changes in Beneficial Ownership (4)
1/30/202317:02EDGARStatement of Changes in Beneficial Ownership (4)
1/30/202317:02EDGARStatement of Changes in Beneficial Ownership (4)
12/30/202217:01EDGARCurrent Report Filing (8-k)
12/27/202208:02EDGARCurrent Report Filing (8-k)
12/08/202208:01EDGARCurrent Report Filing (8-k)
12/08/202208:00BWVBI Vaccines Announces Health Canada Approval for..
12/06/202209:25BWCEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI..
11/22/202208:00EDGARCurrent Report Filing (8-k)
11/22/202208:00BWVBI Vaccines Presents Additional Phase 1/2a Data from..
11/14/202208:00BWVBI Vaccines to Participate in Upcoming Investor Conferences
11/11/202208:00BWVBI Vaccines Announces Presentation of Data from Ongoing..
11/10/202208:01EDGARQuarterly Report (10-q)
11/10/202208:01EDGARCurrent Report Filing (8-k)
11/10/202208:00BWVBI Vaccines Reports Third Quarter 2022 Financial Results..
10/20/202208:00EDGARCurrent Report Filing (8-k)
10/17/202208:00BWVBI Vaccines to Participate in H.C. Wainwright 3rd Annual..
10/12/202208:01EDGARCurrent Report Filing (8-k)
10/12/202208:00GLOBEVBI Vaccines and Agenus Announce Collaboration to Evaluate..
9/29/202208:01EDGARCurrent Report Filing (8-k)
9/29/202208:00BWVBI Vaccines Announces Initiation of Phase 1 Study of..
9/28/202216:13EDGARSmall Company Offering and Sale of Securities Without..
9/21/202208:10EDGARCurrent Report Filing (8-k)
9/21/202208:00BWVBI Vaccines Announces Presentation of Physician-Initiated..
9/15/202217:02EDGARCurrent Report Filing (8-k)
9/15/202208:30BWVBI Vaccines Secures $100 Million Debt Facility From K2..
9/08/202206:11EDGARCurrent Report Filing (8-k)
9/08/202201:00BWValneva and VBI Vaccines Announce European Partnership for..
9/07/202206:05EDGARNotice of Effectiveness (effect)
8/26/202217:04EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/26/202216:42EDGARCurrent Report Filing (8-k)
8/08/202208:02EDGARQuarterly Report (10-q)
8/08/202208:02EDGARCurrent Report Filing (8-k)
8/08/202208:00BWVBI Vaccines Reports Second Quarter 2022 Financial Results..
7/12/202218:21EDGARStatement of Changes in Beneficial Ownership (4)
7/12/202218:18EDGARInitial Statement of Beneficial Ownership (3)
7/12/202208:01EDGARCurrent Report Filing (8-k)
7/12/202208:00BWVBI Vaccines Announces Appointment of John Dillman as Chief..
6/28/202217:48BWVBI Vaccines annonce que de nouvelles données cliniques de..
6/28/202208:01EDGARCurrent Report Filing (8-k)
6/28/202208:00BWVBI Vaccines Announces New Long-Term Follow-Up Clinical Data..
6/23/202206:01EDGARCurrent Report Filing (8-k)
6/22/202216:06BWVBI Vaccines Announces Results of Annual General Meeting
6/22/202208:00BWVBI Vaccines Receives U.S. FDA Orphan Drug Designation for..
6/07/202208:00BWVBI Vaccines to Participate in the Jefferies Healthcare..
6/06/202208:01EDGARCurrent Report Filing (8-k)
6/06/202208:00BWVBI Vaccines Presents Updated Phase 2a Tumor Response and..
6/01/202214:25BWVBI Vaccines annonce l'autorisation de mise sur le marché de..